GlaxoSmithKline, Columbia University, New York University pharmaceuticals news

As of Sept. 20, five research proposals requesting patient-level data from GlaxoSmithKline under the pharma's January open access initiative have been approved. No

Read the full 233 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE